Comparison

Ketamine vs TMS

TMS (transcranial magnetic stimulation) is a non-invasive, non-medication option for depression. Ketamine is a pharmacological option with rapid effects.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: June 4, 2026Evidence: Educational synthesis - not medical advice

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Quick answer

Bottom line

Different tools for different patients. Some clinicians combine or sequence them. Choice depends on tolerance, preference, urgency, and access.

This page compares Ketamine and TMS across the same fixed dimensions - mechanism, evidence, onset, duration, side effects, access, suitability, and limits. It does not name a winner and does not recommend either option for you.

Related on Ketalux

Ketamine

TMS

Mechanism

NMDA-receptor antagonism and downstream plasticity.

Magnetic pulses stimulating cortical regions implicated in depression.

Evidence

Strong short-term TRD response data.

TMS devices are FDA-cleared for treatment-resistant depression; trials report meaningful response and remission rates.

Onset

Hours to days.

Two to six weeks of daily sessions.

Duration

Days to weeks per session.

Often months after a completed course.

Side effects

Dissociation, BP changes, nausea.

Scalp discomfort, headache, rare seizure risk.

Access

Specialty clinics.

Specialty clinics, often insurance-covered.

Best for

Patients seeking rapid response or who have not tolerated medications.

Patients preferring a non-pharmacological, non-dissociative option who can commit to daily sessions.

Limits

Durability requires repeat dosing.

Time commitment for the initial course.

Disclaimer

This comparison is educational and general. It is not a recommendation. Treatment choice depends on your individual history, diagnosis, prior response, preferences, and access - discuss with a qualified clinician.

About the author

Ira Zoot

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.